Latoni D, McDaniel D, Tsao H, Tsao S
JID Innov. 2024; 4(6):100299.
PMID: 39247523
PMC: 11378114.
DOI: 10.1016/j.xjidi.2024.100299.
Gu S, Huang X, Luo S, Liu Y, Khoong Y, Liang H
Mol Ther. 2024; 32(6):1984-1999.
PMID: 38553852
PMC: 11184311.
DOI: 10.1016/j.ymthe.2024.03.031.
Lacombe D, Bloch-Zupan A, Bredrup C, Cooper E, Douzgou Houge S, Garcia-Minaur S
J Med Genet. 2024; 61(6):503-519.
PMID: 38471765
PMC: 11137475.
DOI: 10.1136/jmg-2023-109438.
Bakhtyar N, Amini-Nik S, Jeschke M
Int J Inflam. 2022; 2022:1490492.
PMID: 36483731
PMC: 9722497.
DOI: 10.1155/2022/1490492.
Gibson F, Hanly A, Grbic N, Grunberg N, Wu M, Collard M
Clin Rev Allergy Immunol. 2022; 63(3):447-471.
PMID: 36346551
DOI: 10.1007/s12016-022-08956-8.
The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes.
Amjadian S, Moradi S, Mohammadi P
Skin Pharmacol Physiol. 2022; 35(5):247-265.
PMID: 35696989
PMC: 9533440.
DOI: 10.1159/000524990.
Fibroblast Memory in Development, Homeostasis and Disease.
Kirk T, Ahmed A, Rognoni E
Cells. 2021; 10(11).
PMID: 34831065
PMC: 8616330.
DOI: 10.3390/cells10112840.
Epigenetic regulation of cellular functions in wound healing.
Pastar I, Marjanovic J, Stone R, Chen V, Burgess J, Mervis J
Exp Dermatol. 2021; 30(8):1073-1089.
PMID: 33690920
PMC: 8324509.
DOI: 10.1111/exd.14325.
Non pharmacological high-intensity ultrasound treatment of human dermal fibroblasts to accelerate wound healing.
Lee J, Min D, Kim W, Bin B, Kim K, Cho E
Sci Rep. 2021; 11(1):2465.
PMID: 33510199
PMC: 7844265.
DOI: 10.1038/s41598-021-81878-1.
Epigenetic modification mechanisms involved in keloid: current status and prospect.
Lv W, Ren Y, Hou K, Hu W, Yi Y, Xiong M
Clin Epigenetics. 2020; 12(1):183.
PMID: 33243301
PMC: 7690154.
DOI: 10.1186/s13148-020-00981-8.
Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGFβ1 induced lung and tumor fibrosis.
Zhang W, Zhang Y, Tu T, Schmull S, Han Y, Wang W
Cell Death Dis. 2020; 11(9):765.
PMID: 32943605
PMC: 7499263.
DOI: 10.1038/s41419-020-02916-w.
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease.
Shaw T, Rognoni E
Curr Rheumatol Rep. 2020; 22(8):33.
PMID: 32562113
PMC: 7305072.
DOI: 10.1007/s11926-020-00903-w.
Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring.
El Ayadi A, Jay J, Prasai A
Int J Mol Sci. 2020; 21(3).
PMID: 32046094
PMC: 7037118.
DOI: 10.3390/ijms21031105.
CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2.
Tu T, Huang J, Lin M, Gao Z, Wu X, Zhang W
Int J Mol Med. 2019; 44(5):1789-1800.
PMID: 31545402
PMC: 6777681.
DOI: 10.3892/ijmm.2019.4348.
Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies.
Tan S, Khumalo N, Bayat A
Front Immunol. 2019; 10:1810.
PMID: 31440236
PMC: 6692789.
DOI: 10.3389/fimmu.2019.01810.
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases.
Yoon S, Kang G, Eom G
Int J Mol Sci. 2019; 20(6).
PMID: 30884785
PMC: 6471162.
DOI: 10.3390/ijms20061329.
Epigenetic control in skin development, homeostasis and injury repair.
Kang S, Chovatiya G, Tumbar T
Exp Dermatol. 2019; 28(4):453-463.
PMID: 30624812
PMC: 6488370.
DOI: 10.1111/exd.13872.
JMJD3 and NF-κB-dependent activation of Notch1 gene is required for keratinocyte migration during skin wound healing.
Na J, Shin J, Jeong H, Lee J, Kim B, Kim W
Sci Rep. 2017; 7(1):6494.
PMID: 28747631
PMC: 5529578.
DOI: 10.1038/s41598-017-06750-7.
From genetics to epigenetics: new insights into keloid scarring.
He Y, Deng Z, Alghamdi M, Lu L, Fear M, He L
Cell Prolif. 2017; 50(2).
PMID: 28054407
PMC: 6529126.
DOI: 10.1111/cpr.12326.
HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases.
Yoon S, Eom G
Chonnam Med J. 2016; 52(1):1-11.
PMID: 26865995
PMC: 4742605.
DOI: 10.4068/cmj.2016.52.1.1.
